Elan to create spinoff discovery science company
Elan's board of directors has approved the spinoff of the discovery science and Neotope Biosciences from the company.
Elan's board of directors has approved the spin-off of the discovery science and Neotope Biosciences from the company.
According to a statement from the company, completion of this transaction will create two "independent, highly focused, public companies that will enable investors to align timelines, risk and returns in order to best achieve their investment objectives".
The two companies will be Elan Corporation and Neotape Biosciences.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team